IgM serological diagnostic plays an important role in the dengue epidemiological surveillance. However, IgA has been identified as a possible diagnostic marker for early stage and recent infections. The aim of this study was to know the IgA response in dengue patients in relation to type of infection, serotype specificity and role as early and recent infection marker. IgA behavior in dengue patients, using a method defined as Indirect Sandwich ELISA-IgA (ELISA-IgA) and Capture IgM ELISA (MAC-ELISA) as reference assay was studied. The sensibility and specificity of the system were 91.06% and 83.73% respectively. In acute phase of illness, IgA was only detected in secondary cases with 32.3%. IgM appears later than IgA in secondary cases. No significant differences in IgA or IgM responses between primary and secondary cases were found in samples collected after day 5 of onset of symptoms. In days 41 -54, the percentage of IgA was lower respect to IgM. IgA was detected until day 47 in primary and until day 50 in secondary cases. An elevated cross-reactivity in IgA was observed between dengue serotypes contrary to IgM. The usefulness of IgA, as alternative early diagnostic tool, could be influenced by the absence or very low percentages of positives cases in the first four days of onset of symptoms. However, for definition of secondary infection could be important. IgA could be an alternative tool, better than IgM, as recent infection marker for dengue fever, but this requires more studies in future investigations.
Introduction
Dengue viruses (DENVs) are transmitted to humans by infected mosquitoes, mainly Aedes aegypti and Aedes albopictus. Dengue is the most important mosquito-borne viral disease of humans and an enormous public health burden in affected countries. An estimated of 50 -100 million dengue cases occur annually, including 250,000 -500,000 cases of severe illness and around 25,000 deaths. Approximately 2.5 billion people live in dengue endemic countries and the illness is reported in Southeast Asia, Western Pacific, the Americas, Africa and Mediterranean regions [1] [2] [3] .
DENVs belong to the Flaviviridae family, genus flavivirus. There are four dengue virus serotypes (1, 2, 3, and 4), which are responsible for this disease. Infection by each of the four dengue serotypes can lead to a broad spectrum of outcomes, from asymptomatic and dengue with or without alarm signs and dengue severe form [4] [5] .
There are several reasons why early and accurate diagnosis of dengue is important. An early and accurate diagnosis can assist in patient management by directing clinical attention to the appearance of major warning signs of severe or even life threatening complications, a prompt diagnosis of index cases may facilitate vector control activities in the community and also, an accurate dengue diagnosis prevents unnecessary and possibly expensive antibiotic usage [6] . To count with quick, sure, reliable methods in an early diagnosis, it is of supreme importance for an appropriate surveillance that allows the control of viral transmission and vector [7] [8] .
The IgM antibodies detection against dengue virus is one of the serological markers broadly used in the diagnosis of this illness. They are detectable only starting from 5 to 6 days of onset of fever, which represent a delay in the diagnosis. Another problem is that they may persist in some individuals up to 3 months or more, being complicated the definition of recent infection, mainly in those countries where the illness is endemic [7] . Therefore, some authors have conferred certain value to IgA antibody in regard to early detection, its use in secondary dengue infections and its short duration [9] [10] [11] [12] . However, the studies of this immunoglobulin have been few and its role in the dengue diagnostic is not even well elucidated.
One method used for the detection of IgA antibodies is the capture IgA enzymelinked immunosorbent assay, known as AAC-ELISA [13] [14] [15] . A group of researchers (Yap et al., 2011) developed an ELISA that was defined as ACA-ELISA for the detection of IgA in serum and saliva samples, achieving a high sensitiveness in the detection of these antibodies. With the aim of know the IgA response in dengue patients in relation to primary and secondary infections, serotype specificity and its role as early and recent infection marker, a similar method defined as indirect sandwich ELISA-IgA (ELISA-IgA) was applied in this work.
Material and Methods

Serum Specimens
The DENV-positive and negative samples used in this work were from the dengue sera bank of Arbovirus Laboratory at the "Pedro Kouri" Tropical Medicine Institute of Ha- 
Virus and Antigens
Dengue antigens used in the serological studies were obtained from infected suckling mice brain extracted by the sucrose-acetone method [18] . DENV-1 (Hawaii strain), DENV-2 (New Guinea C strain), DENV-3 (H-87 strain) and DENV-4 (H-241 strain) were used.
Capture IgM ELISA Assay (MAC-ELISA)
MAC-ELISA for the detection of IgM dengue antibody was performed as previously described by Vazquez et al., 2005 [11] . A serum sample was considered positive when the optical density ratio (OD ratio) was ≥2. This value was calculated as P/N where P represents the OD of each serum sample and N represents the mean OD of the negative control wells.
ELISA Inhibition Method (EIM)
EIM for the detection of IgG dengue antibody was performed as previously described by Vazquez et al., 2009 [17] . The inhibition percentage was calculated as:
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The antibody titer of each serum was considered as the highest dilution with a percentage of inhibition ≥50. A serum with a percentage of inhibition <50 was considered negative for IgG dengue antibodies (<20).
Indirect Sandwich ELISA-IgA Assay (ELISA-IgA)
Briefly, each microtiter plate (Greiner Bio-one) was coated with 2.5 µg/mL (100 µL/well) of monoclonal antibody H3/6 anti-dengue complex in sodium carbonate-bicarbonate buffer (pH 9.5) produced in the IPK [19] . The plates were incubated overnight at 4˚C.
After washing the plates were blocked with 1% of bovine serum albumin (BSA, Sigma) and incubated during 1 h at 37˚C. One hundred microliter of mixed virus antigens (16 hemaglutinate units) from mice brain infected with dengue 1, 2, 3 and 4 were incubated for 1 h at 37˚C. After washing, 100 µL of sera and control (1:100) dilutions in PBS-T20 with 5% of milk were added and incubated (1 h at 37˚C). A dilution of 1:20,000 peroxidase-conjugated goat anti-IgA (α chain specific, Sigma) in PBS-T20 with 5% of milk was added (100 µL/well). After incubation (1 h at 37˚C) and washing, orthophenilendiamine (OPD, Merck) and hydrogen peroxide (Merck) in buffer phosphate citrate pH 5 was used as substrate. The optical density (OD) was measured at 492 nm. A serum sample was considered positive when OD ratio was ≥2. This value was calculated as P/N where P represents the OD of each serum sample and N represents the mean OD of the negative control wells. 
Statistical Analysis
Results
Comparison between ELISA-IgA and MAC-ELISA using serum samples collected on days 5 to 7 after fever onset (panel 1).
Three hundred forty five sera corresponding to panel 1 were assayed for the evaluation of ELISA-IgA, using the MAC-ELISA as gold standard. Table 1 In primary, IgM is detectable at day 2 in only two samples, but higher percentages were observed at day 4 (67.0%), while in secondary is detectable at day 1 (3%) increasing the percentage until day 4 (53%). Figure 3 shows the IgA/IgM cross-reactive responses in 16 primary and 18 secondary serum samples from dengue 3 patients, against the four dengue antigens. In primary cases (Figure 3(a) ), the comparison between the infecting serotype (Den-3) and the others serotypes showed significant differences with Den-1 (p = 0.03), but not with Den-2 (p = 0.25) and Den-4 (p = 0.28). Meanwhile, a low IgM cross-reactivity with significant differences (p < 0.001) was found.
In secondary samples (Figure 3(b) ) it was also observed cross-reactivity of IgA, but with higher increase in relation to primary cases. The p values for Den-1, Den-2 and Den-4 were 0.017, 0.21 and 0.83 respectively. The comparison of IgM response of Den-3 with Den-1, 2, 4 serotypes showed significant differences (p = 0.01; p < 0.00).
Discussion
IgM detection in sera is still the preferred marker for the serological diagnosis of dengue infection. However, it could be detected early within 3 -4 days after fever onset, but the majority of infected individuals become positive by day 5 -6 [20] . Also, IgM have been described as persisting until about 3 to 8 months post onset. This implicates a delayed diagnostic and the difficulty in the definition of recent infection, mainly in endemic countries. So, other markers as IgA antibodies and NS1 protein have been se-D. Ruiz et al.
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OALib Journal from primary cases and around 40% at day 4 getting a 100% also at day 7 in secondary cases. Yap et al. 2011 using ACA-ELISA method observed percentages of 15% for primary and 94 for secondary cases in samples collected in the first 3 days of symptom onset, showing an increase in later days. In this study, it was not observed significant differences in IgA percentages between primary and secondary dengue samples collected after day 4, however, in the first four days for primary cases the IgA detection was absent (0%) contrary to 32.3% showed by secondary cases.
As it has been previously commented, in a primary infection IgA antibodies should be detectable after the release of IgM around day 5 of fever onset, while in secondary D. Ruiz et al.
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[20] Balmaseda et al. (2003) found that IgA antibodies were detected in more acutephase sera than were IgM antibodies, pointing out that one explanation for these results could be that IgA levels are higher in secondary infections, which constituted the vast majority of their samples. However, Yap et al. (2011) found higher percentage of IgA that IgM so much in primary as in secondary cases, in the acute phase of the illness.
Ahmed et al. 2010 [23] , using a new commercial IgA rapid test, reported similar percentages of IgM and IgA as much in primary as secondary cases, but De la Cruz et al.
2012 [24] using the same commercial system found higher percentages of IgM in relation to IgA in secondary and inverse in primary cases. The kinetics of IgA detection with respect to the onset of fever seems to vary according to the immune status and seems to appear late in primary cases but very early in secondary cases.
In secondary infection, memory B cells play an important role in rapid and strong production of humoral response that may give higher detectable levels of IgA. Skin immunization utilizes potent bone marrow-derived DCs that are resident in the outer epidermal layers of skin, such as Langerhans cells. These DCs provide immune-surveillance functions, and when they are activated migrate out of the skin to the draining lymph nodes (DLNs) and induce strong antigen specific responses by B and T lymphocytes. This immunization strategy induces robust secretory IgA responses [25] . But, it is common that antigenic stimulation occurs in the secondary lymphoid organ (spleen), where the T and B cell zones are located. However, an early generation of IgA may takes place in local and peripheral lymph nodes due to the directly enter of memory lymphocytes from the blood [26] [27] . On the other hand, a low IgA levels in primary infection reported in previous studies [12] [15] [24] [28] may be explained by the presence of one type of B cell (named B-1 cells) that produce antibodies with poor specificity and do not appear to require help from T cells in their responses to antigens, but may be influenced by the cytokines produced by T cells [27] .
In addition, in this work a significant decrease of IgA percentages in serum samples collected between days 41 and 54 from primary and secondary cases was observed, which could suggest a short life of IgA with respect to IgM. Previous studies have commented this characteristic. Talarmin et al. (1998) reported that IgA antibodies were not detectable after day 40 of onset of fever. Nawa et al. 2005 
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The low cross-reactivity of IgM antibodies and its application for the identification of the dengue virus infecting serotypes has been reported by some authors [30] [31] [32] while IgA cross-reactivity had been poor studied [33] [34] . We found high IgA crossreactivity as much in primary as in secondary cases, contrary to IgM, that showed high specificity against the infecting serotype (dengue 3) in agreement with previous studies.
De Decker et al. [22] showed similar IgA detection for Den-2, 3 and 4, using a commercial Capture IgA ELISA. This result could be described by a high recognition of common epitopes for primary cases and memory B cells activation, producing IgA antibodies against previous serotypes in secondary cases.
Conclusion
Finally, we can say that the utility of IgA as alternative early diagnostic tool could be affected by the absence or very low percentages of positives cases in the first four days of onset of symptoms. However, it's utility in the definition of secondary infection could be important considering the incidence of these cases in (hyper)-endemic areas where more cases are frequently associated with severe outcomes. In sera collected at day 5 or more of fever onset, the IgM may be still considered the favorite marker for serological diagnostic, although IgA could be an alternative tool for primary and secondary cases, keeping in mind its possible use as recent infection marker, which requires more studies in future investigations. The cross-reactivity present in the recognition against the dengue serotypes does not permit the identification of circulating serotype of outbreak. It is necessary to continue the studies of the behaviour of this immunoglobulin to insure a best diagnostic of this illness.
